Complex roles of cAMP–PKA–CREB signaling in cancer

H Zhang, Q Kong, J Wang, Y Jiang, H Hua - Experimental hematology & …, 2020 - Springer
Cyclic adenosine monophosphate (cAMP) is the first discovered second messenger, which
plays pivotal roles in cell signaling, and regulates many physiological and pathological …

Subcellular organization of the cAMP signaling pathway

M Zaccolo, A Zerio, MJ Lobo, C Garland - Pharmacological reviews, 2021 - Elsevier
The field of cAMP signaling is witnessing exciting developments with the recognition that
cAMP is compartmentalized and that spatial regulation of cAMP is critical for faithful signal …

cAMP signaling in cancer: a PKA-CREB and EPAC-centric approach

MB Ahmed, AAA Alghamdi, SU Islam, JS Lee, YS Lee - Cells, 2022 - mdpi.com
Cancer is one of the most common causes of death globally. Despite extensive research
and considerable advances in cancer therapy, the fundamentals of the disease remain …

Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets

MR Paul, T Pan, DK Pant, NNC Shih… - The Journal of …, 2020 - Am Soc Clin Investig
Nearly all breast cancer deaths result from metastatic disease. Despite this, the genomic
events that drive metastatic recurrence are poorly understood. We performed whole-exome …

Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure

R Kamel, J Leroy, G Vandecasteele… - Nature Reviews …, 2023 - nature.com
Cyclic nucleotide phosphodiesterases (PDEs) modulate the neurohormonal regulation of
cardiac function by degrading cAMP and cGMP. In cardiomyocytes, multiple PDE isozymes …

The molecular biology of phosphodiesterase 4 enzymes as pharmacological targets: an interplay of isoforms, conformational states, and inhibitors

D Paes, M Schepers, B Rombaut… - Pharmacological …, 2021 - Elsevier
Abstract The phosphodiesterase 4 (PDE4) enzyme family plays a pivotal role in regulating
levels of the second messenger cAMP. Consequently, PDE4 inhibitors have been …

Gαs–Protein kinase a (PKA) pathway signalopathies: the emerging genetic landscape and therapeutic potential of human diseases driven by aberrant Gαs-PKA …

DJ Ramms, F Raimondi, N Arang, FW Herberg… - Pharmacological …, 2021 - Elsevier
Many of the fundamental concepts of signal transduction and kinase activity are attributed to
the discovery and crystallization of cAMP-dependent protein kinase, or protein kinase A …

[HTML][HTML] Signal transduction in primary cilia–analyzing and manipulating GPCR and second messenger signaling

D Wachten, DU Mick - Pharmacology & therapeutics, 2021 - Elsevier
The primary cilium projects from the surface of most vertebrate cells, where it senses
extracellular signals to regulate diverse cellular processes during tissue development and …

The complexity and multiplicity of the specific cAMP phosphodiesterase family: PDE4, open new adapted therapeutic approaches

C Lugnier - International Journal of Molecular Sciences, 2022 - mdpi.com
Cyclic nucleotides (cAMP, cGMP) play a major role in normal and pathologic signaling.
Beyond receptors, cyclic nucleotide phosphodiesterases;(PDEs) rapidly convert the cyclic …

Cardiac overexpression of PDE4B blunts β-adrenergic response and maladaptive remodeling in heart failure

S Karam, JP Margaria, A Bourcier, D Mika, A Varin… - Circulation, 2020 - Am Heart Assoc
Background: The cyclic AMP (adenosine monophosphate; cAMP)-hydrolyzing protein
PDE4B (phosphodiesterase 4B) is a key negative regulator of cardiac β-adrenergic receptor …